COMPANY
ASPIRE PHARMA LIMITED
ASPIRE PHARMA LIMITED: marketing authorisation holder for Desmopressin, Leuprolide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Desmopressin | DESMOPRESSIN 120 MICROGRAMS SUBLINGUAL TABLETS, PL 35533/0201, Authorised Regulator MHRA |
|---|---|
| Desmopressin | DESMOPRESSIN 240 MICROGRAMS SUBLINGUAL TABLETS, PL 35533/0202, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN 60 MICROGRAMS SUBLINGUAL TABLETS, PL 35533/0200, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN ACETATE 100 MICROGRAM TABLET, PL 35533/0010, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN ACETATE 200 MICROGRAM TABLET, PL 35533/0011, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN SPRAY 10 MICROGRAMS/DOSE, NASAL SPRAY, SOLUTION, PL 35533/0145, Authorised Regulator MHRA |
| Leuprolide | STALADEX 11.25 MG IMPLANT, PL 35533/0269, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.